Track topics on Twitter Track topics that are important to you
RhoVac AB (OMX:RHOVAC) CEO Anders Ljungqvist sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco.
The Sweden and Denmark-based immuno-oncology company is developing a therapeutic cancer vaccine that targets metastatic cancer cells. The company's cancer vaccine product RV001, in clinical trial, recognizes metastatic cancer cells and stimulates the immune system to target them.NEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...